Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Active Not Recruiting Phase 1 Trials for Durvalumab (DB11714)

IndicationStatusPhase
DBCOND0088303 (Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03144778Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell CancerTreatment